"Behcet Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.
| Descriptor ID |
D001528
|
| MeSH Number(s) |
C07.465.075 C11.941.879.780.880.200 C14.907.940.100 C16.320.382.250 C17.800.827.368.250 C17.800.862.150
|
| Concept/Terms |
Behcet Syndrome- Behcet Syndrome
- Triple-Symptom Complex
- Behcet Disease
- Triple Symptom Complex
- Complex, Triple Symptom
- Complices, Triple Symptom
- Symptom Complex, Triple
- Symptom Complices, Triple
- Triple Symptom Complices
- Adamantiades-Behcet Disease
- Adamantiades Behcet Disease
- Adamantiades-Behcet Diseases
- Disease, Adamantiades-Behcet
- Diseases, Adamantiades-Behcet
- Behcet Triple Symptom Complex
- Old Silk Route Disease
- Behcet's Syndrome
- Behcets Syndrome
- Behçet Disease
- Behçet Diseases
- Disease, Behçet
- Diseases, Behçet
|
Below are MeSH descriptors whose meaning is more general than "Behcet Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Behcet Syndrome".
This graph shows the total number of publications written about "Behcet Syndrome" by people in this website by year, and whether "Behcet Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Behcet Syndrome" by people in Profiles.
-
Thomas S, Bae C, Joy-Ann T, Traverse W. Behcet's-like syndrome following pembrolizumab: An immune-related adverse event associated with programmed death receptor-1 inhibitor therapy. J Oncol Pharm Pract. 2020 Jun; 26(4):995-999.
-
Greenhouse DG, Hackett K, Kahn P, Balsam LB, Galloway AC. Giant coronary artery aneurysm in a patient with Beh?et's disease. J Card Surg. 2011 May; 26(3):268-70.
-
Buggage RR, Levy-Clarke G, Sen HN, Ursea R, Srivastava SK, Suhler EB, Altemare C, Velez G, Ragheb J, Chan CC, Nussenblatt RB, Bamji AT, Sran P, Waldmann T, Thompson DJ. A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Beh?et's disease. Ocul Immunol Inflamm. 2007 Mar-Apr; 15(2):63-70.
-
Canataroglu A, Tanriverdi K, Inal T, Seydaoglu G, Arslan D, Ozbek S, Baslamisli F. Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Beh?et's disease. Rheumatol Int. 2003 Sep; 23(5):236-40.
-
Gelber AC, Schachna L, Mitchell L, Schwartzman G, Hartnell G, Geschwind JF. Beh?et's disease complicated by pylephlebitis and hepatic abscesses. Clin Exp Rheumatol. 2001 Sep-Oct; 19(5 Suppl 24):S59-61.
-
Barter SJ, Hicks IP, Hartnell GG, Leung AW. Nuclear magnetic resonance imaging in the assessment of unusual abdominal aortic aneurysms. Clin Radiol. 1985 Jul; 36(4):419-22.